Validation of the HFA-ICOS cardio-oncology cardiovascular risk calculator in an Australian cancer cohort receiving anthracyclines and HER2 targeted therapies
Event:
ESC Cardio-Oncology 2025
Topic:
Stratification, Prevention and Monitoring
Session:
Poster session (1)
